Vanda Pharmaceuticals (VNDA) Cash from Operations Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 85.14% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 74.39% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.23% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 158.60% |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -51.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.50% |
| Dec 31, 2025 | -1,518.99% |
| Sep 30, 2025 | -116.90% |
| Jun 30, 2025 | -120.15% |
| Mar 31, 2025 | -537.93% |
| Dec 31, 2024 | 51.31% |
| Sep 30, 2024 | -611.27% |
| Jun 30, 2024 | 47.59% |
| Mar 31, 2024 | -76.20% |
| Dec 31, 2023 | -139.63% |
| Sep 30, 2023 | -115.97% |
| Jun 30, 2023 | -332.54% |
| Mar 31, 2023 | 686.04% |
| Dec 31, 2022 | -64.61% |
| Sep 30, 2022 | 36.61% |
| Jun 30, 2022 | -70.11% |
| Mar 31, 2022 | -55.99% |
| Dec 31, 2021 | 37.85% |
| Sep 30, 2021 | 0.25% |
| Jun 30, 2021 | -20.78% |
| Mar 31, 2021 | 1,113.56% |
| Dec 31, 2020 | 97.14% |
| Sep 30, 2020 | 56.29% |
| Jun 30, 2020 | 17.02% |
| Mar 31, 2020 | -109.41% |
| Dec 31, 2019 | -35.85% |
| Sep 30, 2019 | -31.01% |
| Jun 30, 2019 | 367.21% |
| Mar 31, 2019 | 488.71% |
| Dec 31, 2018 | 340.36% |
| Sep 30, 2018 | 301.01% |
| Jun 30, 2018 | 294.29% |
| Mar 31, 2018 | 130.58% |
| Dec 31, 2017 | 392.98% |
| Sep 30, 2017 | 74.70% |
| Jun 30, 2017 | 30.72% |
| Mar 31, 2017 | -9.35% |
| Dec 31, 2016 | -232.30% |
| Sep 30, 2016 | 125.58% |
| Jun 30, 2016 | -126.96% |
| Mar 31, 2016 | -188.19% |
| Dec 31, 2015 | 97.34% |
| Sep 30, 2015 | 36.16% |
| Jun 30, 2015 | 133.00% |
| Mar 31, 2015 | 123.24% |
| Dec 31, 2014 | -10.15% |
| Sep 30, 2014 | 26.01% |
| Jun 30, 2014 | -355.86% |
| Mar 31, 2014 | -161.96% |
| Dec 31, 2013 | 12.25% |
| Sep 30, 2013 | -1.05% |
| Jun 30, 2013 | 34.15% |
| Mar 31, 2013 | -5.01% |
| Dec 31, 2012 | -12.07% |
| Sep 30, 2012 | -41.76% |
| Jun 30, 2012 | -117.37% |
| Mar 31, 2012 | -166.24% |
| Dec 31, 2011 | -142.48% |
| Sep 30, 2011 | -41.31% |